| Monica Kirkpatrick, | |
|
111 S Potomac St, Hagerstown, MD 21740-6680 | |
| (833) 782-2247 | |
| Not Available |
| Full Name | Monica Kirkpatrick |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 111 S Potomac St, Hagerstown, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023623550 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | SC1045 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Monica Kirkpatrick, 111 S Potomac St, Hagerstown, MD 21740-6680 Ph: () - | Monica Kirkpatrick, 111 S Potomac St, Hagerstown, MD 21740-6680 Ph: (833) 782-2247 |
News Archive
The cure rates for many cancers have improved dramatically over the past decades, but the harsh reality is that too many cancer survivors suffer serious side-effects of their curative treatments. Toxic side-effects can occur months or years after the treatments are finished, sometimes as chronic conditions, sometimes life-threatening, but always unacceptably reducing a patient's quality of life.
Nearly 50 million Americans have metabolic syndrome, a cluster of risk factors placing them at increased risk of developing cardiovascular disease.
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events.
The Executive Order President Obama issued Monday directing the U.S. Food and Drug Administration to take action to reduce prescription drug shortages is a commendable first step, but the White House could strengthen its directive and address the full scope of the problem by ordering mandatory reporting by manufacturers, which The Endocrine Society calls for in its Position Statement on drug shortages.
Shire plc, the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi & Co. Ltd. of Japan to co-develop and co-commercialize certain of Shire's Attention Deficit Hyperactivity Disorder (ADHD) medicines in Japan.
› Verified 9 days ago
Mr. William Thomas Menter, CCDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 13114 Pennsylvania Ave, Hagerstown, MD 21742 Phone: 240-313-3386 Fax: 240-313-3316 | |
April D Lehman, L.G.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 13114 Pennsylvania Ave, Hagerstown, MD 21742 Phone: 240-313-3291 Fax: 240-313-3239 | |
Brittany Horchner, Counselor Medicare: Not Enrolled in Medicare Practice Location: 322 E Antietam St Ste 307a, Hagerstown, MD 21740 Phone: 240-513-6127 | |
Ryann Fiery, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 201 N Burhans Blvd, Hagerstown, MD 21740 Phone: 301-791-2660 | |
Allen L Twigg, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-766-7600 Fax: 301-766-7702 | |
Mrs. Georgette Geraldine Hughes, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 18714 N Village, Hagerstown, MD 21742 Phone: 301-733-0331 Fax: 301-733-4038 | |
Brittany Kuhn, LGPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5 Public Sq Ste 205, Hagerstown, MD 21740 Phone: 240-724-1437 |